β¨ Health Notices
7 JULY 2005
NEW ZEALAND GAZETTE, No. 105
as chair of the Ethics Committee on Assisted Reproductive
Technology for a three-year term of office commencing
from the date in this notification; and
Lynley Anderson
Eamon Daly
John Hutton
to the Ethics Committee on Assisted Reproductive
Technology for three-year terms of office commencing from
the date in this notification; and
Sharron Cole
Robert Elliott
Christine Forster
Maui Hudson
to the Ethics Committee on Assisted Reproductive
Technology for two-year terms of office commencing from
the date in this notification.
Dated at Wellington this 23rd day of June 2005.
ANNETTE KING, Minister of Health.
go4193
Medicines Act 1981
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set
out in the Schedule hereto:
Schedule
Product: Ciproxin
Active Ingredient: Ciprofloxacin lactate 2.54mg/mL equivalent to ciprofloxacin 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Leverkusen, Germany
Product: Ciproxin
Active Ingredient: Ciprofloxacin 10g
Dosage Form: Microcapsules granules for oral suspension
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer SpA, Garbagnate, Milanese, Italy
Product: Ciproxin
Active Ingredient: Ciprofloxacin 2.5g
Dosage Form: Microcapsules granules for oral suspension
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer SpA, Garbagnate, Milanese, Italy
Product: Ciproxin
Active Ingredient: Ciprofloxacin hydrochloride 116.4mg equivalent to ciprofloxacin 100mg as monohydrate
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Leverkusen, Germany
Product: Ciproxin
Active Ingredient: Ciprofloxacin hydrochloride 291mg equivalent to ciprofloxacin 250mg as monohydrate
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Leverkusen, Germany
Product: Ciproxin
Active Ingredient: Ciprofloxacin hydrochloride 582mg equivalent to ciprofloxacin 500mg as monohydrate
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Leverkusen, Germany
Product: Ciproxin
Active Ingredient: Ciprofloxacin hydrochloride 873mg equivalent to ciprofloxacin 750mg as monohydrate
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer Diagnostics New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Leverkusen, Germany
Dated this 1st day of July 2005.
MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on
6 July 2001).
go4256
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 105
Gazette.govt.nz —
NZ Gazette 2005, No 105
β¨ LLM interpretation of page content
π₯
Ethics Committee on Assisted Reproductive Technology Appointment
(continued from previous page)
π₯ Health & Social Welfare23 June 2005
Ethics Committee on Assisted Reproductive Technology, Appointment, Human Assisted Reproductive Technology Act 2004
7 names identified
- Lynley Anderson, Appointed to Ethics Committee
- Eamon Daly, Appointed to Ethics Committee
- John Hutton, Appointed to Ethics Committee
- Sharron Cole, Appointed to Ethics Committee
- Robert Elliott, Appointed to Ethics Committee
- Christine Forster, Appointed to Ethics Committee
- Maui Hudson, Appointed to Ethics Committee
- Aninette King, Minister of Health
π₯ Consent to Distribution of Changed Medicine
π₯ Health & Social Welfare1 July 2005
Medicines Act 1981, Changed Medicine, Consent, Ciproxin
- Mark Jacobs, Acting Deputy Director-General, Public Health